Metabolic Solutions Development Co. LLC
Treating metabolic disease by way of the mitochondria
This article was originally published in Start Up
Executive Summary
Metabolic Solutions Development thinks it knows why diabetes drugs directed against PPAR-γ ran into safety problems. The start-up is leveraging insights about what not to do, as it works to create an insulin sensitizer that lowers blood glucose levels without increasing white fat and without causing dangerous side effects.